May, 2018 | The Wall Street Analyzer

Latest News

[ June 10, 2021 ] Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test Kit Now Available for Sale in US News Feed
[ June 9, 2021 ] GOLDEN INDEPENDENCE ANNOUNCES CLOSING OF PRIVATE PLACEMENT FINANCING News Feed
[ June 4, 2021 ] Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules News Feed
[ June 4, 2021 ] City View Green Holdings Inc. and Budd Hutt Inc. Open Second Retail Cannabis Store in Grande Cache, Alberta News Feed
[ June 3, 2021 ] Golden Independence Announces Private Placement Financing News Feed
[ May 26, 2021 ] Citius Pharmaceuticals Selected to Receive Best Poster Award at the International Society for Cell and Gene Therapy 2021 Annual Meeting News Feed
[ May 19, 2021 ] Ocuphire Granted Two New U.S. Patents Covering Late-Stage Drug Candidate Nyxol®, Including for the Treatment of Presbyopia News Feed

Pyxis Tankers (NASDAQ: PXS) Management Interview

May 30, 2018 The Wall Street Analyzer Comments Off

Management Interview […]

iAnthus Capital Holdings (OTCQB: ITHUF) (CSE: IAN) CEO: Hadley Ford

May 30, 2018 The Wall Street Analyzer Comments Off

Interview with Hadley Ford, CEO […]

Victoria Gold Provides Eagle Development Update, Yukon Territory

May 25, 2018 The Wall Street Analyzer Comments Off

TORONTO, May 24, 2018 (GLOBE NEWSWIRE) — Victoria Gold Corp. (TSX-V:VIT) “Victoria” or the “Company” is pleased to provide a construction update for the Eagle Gold Mine Project (the “Project”), Yukon Canada. Full construction commenced […]

Acerus Pharmaceuticals Corporation (TSX: ASP) CEO: Ed Gudaitis

May 23, 2018 The Wall Street Analyzer Comments Off

Founded in 2008, Acerus has quickly grown into a fully integrated company with expertise in all stages of the pharmaceutical product lifecycle, and focus in the therapeutic areas of Men’s Health (Urology) and Women’s Health (Hormone Replacement Therapy, Female Sexual Dysfunction). […]

Aerkomm Inc. (OTCQX: AKOM) CEO Interview

May 23, 2018 The Wall Street Analyzer Comments Off

Interview with Jeffrey Wun, CEO […]

Well Leveraged: VBI Vaccines Outlines Clinical Trial Progress

May 23, 2018 The Wall Street Analyzer Comments Off

NEW YORK, May 22, 2018 (GLOBE NEWSWIRE) — Jeff Baxter, President and CEO of VBI Vaccines Inc. (NASDAQ:VBIV), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, took time to update WSA’s investor […]